FORMAC Pharmaceuticals announces collaboration with W. R. Grace & Co.’s Discovery Sciences
Advertisement
FORMAC Pharmaceuticals NV announced that it has entered into a multiyear global strategic partnership with W. R. Grace & Co.’s Discovery Sciences to develop new silica based drug products.
FORMAC will be responsible for the discovery and preclinical development of new small molecule candidate drugs that may benefit from its unique silica based drug delivery approach. The alliance will make use of FORMAC´s proprietary high throughput screening platform for identification of optimal silica-drug combinations. W.R. Grace & Co will provide material expertise, scale-up and commercialization for new optimized materials for drug delivery.